Browse A-Z
VC Funds Starting with 0-9
72 funds found
01 Advisors is a venture capital firm founded in 2018 by former Twitter executives Dick Costolo and Adam Bain. Based in San Francisco, California, 01 Advisors focuses on early to growth-stage investments, particularly in the software, fintech, and tech-enabled services sectors. The firm aims to leverage its extensive operational experience to support startups transitioning from product development to building scalable businesses. The investment strategy of 01 Advisors includes backing visionary founders and providing strategic guidance to help them scale their companies. Notable investments include companies like Tipalti, Density, and Electric, which span industries such as financial software, electronic equipment, and IT consulting. The firm has raised multiple funds, with their first fund closing at $134 million and their third fund managing $395 million. They continue to be active investors, having made 55 investments to date, and are known for their hands-on approach in nurturing portfolio companies from the early stages through to potential exits.
021 Capital is a venture capital firm based in Bengaluru, India, founded in 2017 by Sailesh Tulshan, with Binny Bansal (co-founder of Flipkart) as an advisor. The fund focuses on early-stage investments, particularly in biotechnology, agritech, and technology sectors, with a goal of fostering innovation in fields like artificial intelligence, SaaS, and life sciences. The firm is known for its investments in high-potential startups like BharatAgri, BarRaiser, and Increff, supporting companies with rounds ranging from $1M to $12M. 021 Capital provides not only capital but also strategic guidance, helping startups scale rapidly. The firm typically participates in seed, Series A, and Series B rounds, and its investment size ranges from $1M to $6M per deal. 021 Capital's portfolio reflects a diverse interest across sectors such as agriculture, fintech, retail, and e-commerce, emphasizing sustainability and technological advancements in industries that can make significant societal impacts.
100 Black Angels & Allies is a venture capital fund dedicated to building an inclusive Black technology and startup ecosystem. Their mission is to harness the power of Black and ally investors to close the racial wealth gap and promote equitable representation in tech and entrepreneurship. The fund focuses on investing in early-stage startups, particularly those contributing to the Fourth Industrial Revolution, across sectors such as technology, finance, and climate solutions. Notable portfolio companies include Rheaply, Solo Funds, and Kanarys, all of which align with the fund’s vision of creating scalable impact-driven solutions. With investments targeting Black founders and underrepresented entrepreneurs, 100 Black Angels & Allies is committed to fostering multi-generational wealth creation without reliance on existing wealth. Led by a team of seasoned investors, including Managing General Partner Rodney Sampson and General Partner Heather Hiles, the fund is actively involved in mentorship and ecosystem-building efforts, aiming to democratize access to capital and entrepreneurial success.
The John D. and Catherine T. MacArthur Foundation, commonly known as the MacArthur Foundation, is a prominent philanthropic organization based in Chicago, Illinois. Founded in 1970, the Foundation is dedicated to supporting creative individuals and effective institutions committed to building a more just, verdant, and peaceful world. The Foundation’s work spans several key areas, including climate solutions, criminal justice reform, local journalism, and global security. One of its signature initiatives is the MacArthur Fellows Program, often referred to as the "Genius Grant," which awards $800,000 in no-strings-attached funding to extraordinarily talented and creative individuals across various fields. Another significant initiative is the 100&Change competition, where the Foundation awards a $100 million grant to a single project that addresses a critical global problem. This competition runs every four years and is designed to fund solutions that are impactful, evidence-based, and sustainable. The Foundation also emphasizes technology’s role in public interest, supporting initiatives that advance equity and justice in the digital age. In response to the COVID-19 pandemic, the MacArthur Foundation launched the Equitable Recovery program, committing $125 million to address structural racism and improve public health and housing systems.
The 100+ Accelerator was launched in 2018 by AB InBev and is now co-sponsored by major global companies like Coca-Cola, Colgate-Palmolive, Danone, and Unilever. This initiative is designed to support sustainability startups that align with the UN’s Sustainable Development Goals (SDGs). The program provides selected startups with up to $100,000 in funding for pilot projects that address sustainability challenges in sectors such as circular economy, water stewardship, sustainable agriculture, climate action, and biodiversity. The accelerator runs a six-month remote program where startups receive mentorship from industry experts, training, and opportunities to collaborate with these major corporations. The goal is to help startups validate their solutions through pilot projects and eventually scale them through long-term commercial contracts. Over 148 startups from 38 countries have participated in the program. Startups that successfully complete the program are positioned to significantly impact global supply chains, and the accelerator’s Demo Day offers opportunities to pitch to world-class investors.
10X Capital is a versatile alternative asset management firm headquartered in New York City, specializing in providing institutional investors access to high-growth opportunities across various asset classes. Founded by Hans Thomas and co-headed by David Weisburd, the firm aligns Wall Street with Silicon Valley, focusing on venture capital, private credit, private equity, and real estate investments. 10X Capital’s notable strategies include venture capital investments in high-growth technology companies through private equity and public markets. They also manage SPACs, IPOs, and securitization, leveraging a deep network and robust analytical capabilities to identify and nurture promising startups. The firm has successfully facilitated the growth of several technology-driven businesses, effectively bridging the gap between institutional capital and innovative ventures. Key team members include Russell Read, Chief Investment Officer, who brings extensive experience from CalPERS and the Alaska Permanent Fund, and Guhan Kandasamy, Chief Data Officer, known for his expertise in credit risk and data management. The team’s diverse background enables 10X Capital to provide comprehensive support and strategic insights to their portfolio companies. The firm’s mission is to democratize access to capital markets, ensuring that high-potential ventures receive the necessary funding and support to scale efficiently. This commitment is evident in their broad range of services and their strategic focus on sectors like technology, real estate, and specialty finance
11.2 Capital is an early-stage venture capital firm based in San Francisco, focusing on breakthrough technologies in artificial intelligence, augmented reality/virtual reality (AR/VR), robotics, space, and data-driven health. They have built a diverse portfolio that includes companies such as Bay Labs, Deep Genomics, and Hinge Health. Their investment strategy centers on early-stage technology startups with the potential for significant impact. 11.2 Capital has made 51 investments, with notable exits including Cruise Automation and Kindred AI. They emphasize supporting companies that leverage data at molecular and behavioral levels to innovate in healthcare, such as Apixio and Hindsait, which use data to enhance patient care and reduce costs. The firm is led by a team with deep expertise in technology and investment. Shelley Zhuang, a notable figure in the venture capital world, brings extensive knowledge in cybersecurity and AI. 11.2 Capital's approach involves not only providing capital but also strategic support to help startups scale effectively. Overall, 11.2 Capital is dedicated to fostering innovation in tech-driven sectors, providing both financial backing and strategic partnerships to enable startups to reach their full potential.
13 Ventures is a U.S.-based venture capital fund specializing in consumer-facing companies that are already generating revenue and are on a strong growth trajectory. The fund is particularly interested in businesses that demonstrate a clear path to profitability, aiming to back scalable models that can quickly capitalize on market opportunities. While their check sizes and deal specifics are not publicized, they focus on later stages, supporting companies in growing their market presence and operational capacity. Startups are encouraged to have a strong product-market fit and be ready for strategic scaling before approaching the fund. The fund emphasizes the importance of introductions, signaling that they prefer startups to come through a trusted network or via direct recommendations. They value concise and well-prepared pitches that highlight key business metrics such as revenue growth and market positioning. The goal is to ensure each company aligns with 13 Ventures' investment thesis, which centers around robust consumer-driven companies poised for significant expansion. 13 Ventures offers more than just capital; they provide hands-on support to help their portfolio companies overcome operational and growth challenges. Their experience and extensive network provide startups with access to critical resources, including mentorship and partnerships that can accelerate growth. Their ideal investments are in companies that have already proven their ability to generate revenue and are ready to scale to the next level, with a firm foundation and potential for profitability. This focus on high-growth consumer markets sets 13 Ventures apart as a key player in helping companies scale effectively.
1517 Fund, co-founded in 2015 by Michael Gibson and Danielle Strachman, is a venture capital firm with a distinctive focus on backing young founders, dropouts, and renegade scientists. The firm is inspired by the spirit of Martin Luther's 1517 Reformation, challenging the conventional education system and supporting innovators working outside traditional academic tracks. 1517 Fund invests in early-stage startups, including those at the R&D/idea phase up to the Seed stage. They are particularly interested in software, hardware with a data play, deep tech/science fiction tech, and biotech. Their initial investments range from $50,000 to $1,000,000, with an average check size of around $400,000 for pre-seed investments. Notable companies in 1517 Fund's portfolio include Luminar, Lambda, Deepgram, and Figma. They have a community-oriented approach, providing grants, investments, and support to a network of hackers, makers, and scientists globally. This community includes events, workshops, and office hours aimed at fostering innovation and advancing the edges of knowledge and science. The fund's co-founders, Michael Gibson and Danielle Strachman, previously worked with Peter Thiel on the Thiel Fellowship, which provided $100k grants to young entrepreneurs, leading to successful ventures like Ethereum and OYO Rooms. This background underscores their commitment to nurturing unconventional talent and groundbreaking ideas.
1776 Ventures, based in Washington, D.C., is a seed-stage venture capital firm with a focus on transformative startups addressing critical societal needs. Notable investments include Twiga Foods, a Nairobi-based agriculture and e-commerce platform; MPOWER Financing, providing financial services for higher education; and HopSkipDrive, a transportation solution for children. The fund primarily invests in sectors like healthcare, education, energy, smart cities, and fintech. Geographically, 1776 Ventures has a diverse portfolio with significant activity in the United States, particularly in California, Washington D.C., and New York, as well as international investments in Kenya and Brazil. Their strategy emphasizes early-stage investments, mostly seed and occasionally Series A rounds. They prefer to follow rather than lead, with an average check size of $3 million and typically around ten rounds per year. The firm was co-founded by Donna Harris and Evan Burfield, who bring extensive expertise and networks to support portfolio companies. They actively seek startups with strong potential for social impact and scalability. To approach 1776 Ventures, it is beneficial to have a clear demonstration of market need and a scalable business model. For startups looking to engage with 1776 Ventures, highlighting innovation in complex and high-impact sectors is crucial. The firm values proactive outreach from founders who can articulate a clear vision and demonstrate a tangible plan for growth and impact.
1855 Capital is a seed and early-stage venture capital fund based in State College, Pennsylvania, with a focus on investing in startups connected to Penn State University. The fund, which has approximately $10 million under management, is dedicated to supporting companies emerging from Penn State's robust research and educational environment. This includes faculty, staff, students, and the extensive alumni network of over 700,000 members. The firm primarily targets sectors like information technology, advanced materials, fintech, edtech, and healthcare/medical devices. Investments typically range from $100,000 to $500,000, aiming to fill a critical early-stage funding gap for Penn State-affiliated startups, particularly those in underserved regions of Pennsylvania. The fund leverages its deep ties to the university and the broader business community to provide not just capital but also mentorship and strategic guidance, helping startups achieve significant milestones and scale effectively. Led by Managing Director Matt Rhodes, who has extensive experience in both startup and large-scale business management, 1855 Capital is committed to driving innovation within the Penn State ecosystem.
186 Ventures is a Boston-based venture capital firm, established in 2021, managing a $37M seed fund. Co-founded by Giuseppe Stuto and Julian Fialkow, the firm focuses on pre-seed and seed-stage investments, primarily in software sectors. They have a strong presence in fintech, AI, healthtech, blockchain, and SaaS. While their primary focus is on the Northeastern U.S., they also target high-growth startups across other major hubs like New York and San Francisco. 186 Ventures takes a generalist approach, investing in a wide range of tech-enabled companies but prioritizes capital-efficient startups that can demonstrate sustainable business models. With over 30 companies in their portfolio, including notable names like Centaur Labs, SuperWorld, and Monitaur, the firm aims to build out its portfolio further with 8-10 new investments in 2024. They are particularly founder-focused, offering strategic and operational support while leveraging their extensive network of operators and industry leaders to drive growth. Their average check size varies, but they typically lead early-stage rounds, with a keen eye on startups with strong capital efficiency and rapid growth potential. The team at 186 Ventures is highly accessible and hands-on, valuing founder alignment and supporting businesses through both market highs and lows.
1863 Ventures is a Washington, D.C.-based nonprofit business development accelerator and venture capital fund dedicated to supporting "New Majority" founders—primarily Black, Latino, and other historically underestimated entrepreneurs. Founded by Melissa Bradley in 2016, 1863 Ventures is committed to creating $100 billion in new wealth for these entrepreneurs by helping them scale from high potential to high growth. The organization offers a comprehensive suite of programs, including tailored curricula, access to capital, mentorship, and corporate partnerships, all designed to address the unique challenges faced by New Majority entrepreneurs. 1863 Ventures has supported over 3,200 entrepreneurs across the U.S., helping them generate significant revenue and raise millions in equity and debt financing. Through its venture fund, 1863 Ventures has invested in a diverse portfolio of startups across various industries, such as software development, food products, and e-commerce. Notable investments include companies like Bonnti, Flexie, and Trade Street Jam. 1863 Ventures' impact is deeply rooted in its commitment to economic empowerment and racial equity, making it a leading force in transforming the entrepreneurial landscape for underrepresented communities.
1955 Capital is a venture capital firm based in Los Altos, California, founded by Andrew Chung in 2015. The firm focuses on investing in advanced technologies from the Americas and Europe that can address significant challenges in developing countries, particularly in areas like energy, environment, food safety, health, education, and sustainable manufacturing. 1955 Capital’s investment strategy is driven by a mission to leverage breakthrough technologies to tackle some of the world’s most pressing issues. The firm aims to foster global partnerships, accelerate technology commercialization, and create substantial market opportunities. Their approach is deeply informed by the founder’s extensive experience in sustainability and health technologies, including involvement with several unicorns in these sectors during his time at Khosla Ventures. The firm has built a diverse portfolio, investing in companies that are pioneering innovative solutions across various industries. For instance, they have supported ventures in electric aviation, alternative proteins, energy storage, and surgical robotics. By focusing on these high-impact sectors, 1955 Capital seeks to create both financial returns and positive global change.
1982 Ventures is a prominent venture capital firm based in Singapore, specializing in early-stage fintech investments across Southeast Asia. Founded in 2019 by Scott Krivokopich and Herston Powers, the firm focuses on seed-stage investments, particularly in fintech companies in Indonesia, Vietnam, the Philippines, and Singapore. They are committed to fostering the growth of fintech infrastructure in one of the world's fastest-growing regions. 1982 Ventures boasts a diverse portfolio that includes companies like iPiD, Untukmu.AI, and Bluesheets. They are noted for their deep network and ability to provide valuable introductions to other investors, customers, and talent, significantly benefiting their portfolio companies. Their approach includes offering strategic support through their extensive experience in financial services and fintech. The firm is the most active fintech investor in Southeast Asia, aiming to fill a critical gap in the VC market by focusing on early-stage fintech companies. This focus is driven by the rapid economic growth, a large and growing middle-class population, and high rates of tech adoption in the region. 1982 Ventures also places a strong emphasis on building relationships and providing strategic value beyond capital, positioning themselves as a committed partner in the fintech ecosystem. They recently expanded their team with key hires to support strategic stakeholder relations and ecosystem development, underscoring their commitment to growing their impact throughout the region.
1984 Ventures, founded in 2018 and based in San Francisco, is a venture capital firm focusing on seed and early-stage investments in software businesses. The firm targets sectors such as fintech, healthcare, SaaS, e-commerce, and consumer technology. Their portfolio includes notable companies like Properly, Brace, and Heroes Jobs. The firm has made 120 investments, with 9 successful exits to date, including Convex, which was acquired in 2024. 1984 Ventures has recently invested in companies like Fay, Collaborative Robotics, and Alaffia Health in 2024. 1984 Ventures is led by founder and managing partner Ramy Adeeb, and they leverage their entrepreneurial experience to help portfolio companies grow. They emphasize supporting startups that apply technology to solve real-world problems.
1confirmation is a venture capital firm founded by Nick Tomaino, focusing primarily on early-stage investments in the blockchain and cryptocurrency sectors. Based in San Francisco, the firm aims to support open networks that empower the masses by investing in companies that are building innovative blockchain-based solutions. 1confirmation's portfolio includes notable investments in companies like OpenSea, dYdX, and Nexus Mutual, highlighting their strong focus on the cryptocurrency space. Their investment strategy emphasizes early-stage opportunities, providing not just capital but also strategic guidance and industry connections to help startups grow. The firm is known for its deep commitment to the crypto ecosystem, often being one of the first institutional investors in pioneering blockchain projects. This approach allows them to take significant risks with the potential for high returns, following a philosophy that values transformational technologies over immediate profitability. The team at 1confirmation includes experienced professionals with a strong background in both venture capital and the cryptocurrency industry, allowing them to leverage their expertise and networks to support the growth of their portfolio companies effectively.
1kx is a venture capital firm founded in 2018, specializing in early-stage investments with a focus on blockchain technology and decentralized ecosystems. The firm is headquartered in Road Town, British Virgin Islands, with additional offices in Berlin and Amsterdam. 1kx has made notable investments in several high-profile projects within the blockchain and DeFi sectors. Some of their key investments include Qredo, a blockchain network for DeFi applications; Matter Labs, which focuses on blockchain privacy and verifiable computation; and Rarible, an online marketplace for blockchain-based digital art. Other significant investments include Connext, which offers Ethereum-based P2P micro-payment infrastructure, and Gitcoin, a platform for funding open-source software development. The firm's investment strategy emphasizes supporting projects that build critical infrastructure for decentralized ecosystems. They have made 162 investments to date, with a strong presence in the United States, followed by Germany and France. The leadership team at 1kx includes founding partners Christopher Heymann and Lasse Clausen, along with Diana Biggs, who supports portfolio growth with an institutional lens.
1Up Ventures is a venture capital fund dedicated to supporting independent game developers. Founded by Ed Fries, a former Microsoft executive who played a pivotal role in the development of the Xbox, the fund is based in Kirkland, Washington. 1Up Ventures emphasizes building a diverse and inclusive community of talented, experienced, and creative indie game developers. The fund focuses exclusively on investing in game and content-focused studios, not platforms or tech-focused studios. 1Up Ventures typically does not act as a lead investor but supports founders through a community-driven approach. They invest a standard amount and percentage in their portfolio companies, emphasizing collaborative success. Key team members include Kelly Wallick, a partner and community builder who is also the founder of Indie MEGABOOTH, and Chris Wheaton, the fund administrator with extensive industry experience as a CFO, COO, and General Manager. The fund's portfolio features a variety of innovative game development studios, reflecting their commitment to a broad and inclusive portfolio approach.
212 Angels, also known as 212 Ventures, is a leading venture capital firm focused on backing B2B technology startups that are ready to scale globally. Based in Istanbul, with additional offices in Doha, Dubai, and San Francisco, 212 has a strong regional presence but operates with a global perspective. The firm has invested in numerous innovative companies, supporting them through various stages of growth. Notable investments include Metrobi, a last-mile logistics platform, and Fazla, which provides tech-enabled solutions for waste management and has significantly reduced food waste and carbon emissions. Other key portfolio companies are Trio Mobil, which offers industrial IoT solutions, and AppSamurai, a mobile marketing technology firm. 212 Angels typically invests in seed to Series A rounds, with initial investments ranging from $500K to $5M. They focus on sectors like fintech, logistics, AI, and SaaS, providing both capital and strategic support to help startups expand internationally. Their approach emphasizes a hands-on partnership with founders, leveraging their extensive network and expertise to drive growth. The leadership team, including founder and managing director Ali Karabey, brings a wealth of experience in venture capital and entrepreneurship. They pride themselves on their ability to identify and nurture high-potential startups, helping them navigate the challenges of scaling and achieving global success. For startups looking to attract investment from 212 Angels, it’s crucial to demonstrate a strong product-market fit and potential for international growth. The firm values innovation, scalability, and the ability to solve significant problems in their respective industries.
2048 Ventures is a venture capital firm founded in 2018 and headquartered in New York, NY. The firm focuses on early-stage investments, particularly in technology-driven startups. They have a strong portfolio with over 120 investments across diverse sectors, including biotechnology, artificial intelligence, health tech, and commercial products. Some notable companies backed by 2048 Ventures include Adaptis Technologies, an AI-powered platform for optimizing the carbon footprint of buildings, and Fathom Optics, which delivers 3D experiences using standard printing technologies. Their investment strategy is to support visionary founders at the earliest stages, often leading pre-seed and seed rounds. 2048 Ventures has shown significant activity, with their portfolio companies collectively raising $591 million and reaching a valuation of $2.6 billion by the end of 2023. They have invested in innovative companies like TwoStep Therapeutics, which specializes in modular peptide technology for targeting solid tumors, and Century Health, which leverages AI to accelerate drug development.
2150 is a London, Copenhagen, and Berlin-based venture capital firm focused on transforming urban environments through sustainable technology. With a €268 million fund, 2150 invests in companies that address major challenges across the "Urban Stack"—everything from the design and construction of cities to how they are powered and maintained. Their mission is to support groundbreaking startups that can reimagine urban living, while significantly reducing carbon emissions and improving sustainability. 2150 primarily invests in Series A and B stage companies, with check sizes ranging from $1 million to $7 million. Their focus spans climate tech, green solutions, and innovative materials, all aimed at creating smarter, more efficient cities. The firm’s portfolio includes companies like CarbonCure, which injects recycled CO₂ into concrete to reduce its carbon footprint, Normative, a platform that helps businesses track and manage their carbon emissions, and Ampd Energy, which electrifies construction sites to minimize pollution. Beyond financial backing, 2150 takes a hands-on approach, working closely with founders to scale their businesses and maximize impact. The firm’s ultimate goal is to build a portfolio capable of mitigating gigatonnes of CO₂ emissions, comparable to the entire annual output of countries like Germany and France. With strong backing from investors like Novo Holdings and the BMW Foundation, 2150 is positioned as a key player in the future of urban development, driving both commercial success and global sustainability.
25madison, established in 2018, is a venture capital firm and startup studio based in New York City. The firm specializes in co-incubating ideas, investing in early-stage startups, and propelling companies into their next growth phase. The venture studio and fund focus on pre-seed to seed-stage investments, particularly in healthcare, fintech, and B2B SaaS sectors. 25madison operates a comprehensive platform that includes a flagship venture studio, a dedicated healthtech studio, and a supply chain studio. This platform supports startups by providing strategic guidance, operational expertise, and capital. The firm prides itself on its bespoke model for early-stage businesses, offering hands-on involvement in business strategy, product development, brand creation, and go-to-market execution. The team at 25madison includes experienced entrepreneurs and investors who bring deep industry knowledge and a track record of building and scaling successful companies. Key team members include Matthew Fremont-Smith, Steven Price, and Michael Lynton. Notable investments from 25madison include companies like Truehold, Pattern, and Handspring Health, which showcase their commitment to transformative products and innovative business models. The firm also collaborates closely with Apollo Global Management, leveraging their network and resources to enhance their startups' growth prospects.
27V (Twenty Seven Ventures) is a venture capital firm that focuses on early-stage investments in EdTech (education technology) and Future of Work startups. The firm was founded by Atin Batra and is headquartered in the Cayman Islands. Since its inception in late 2019, 27V has invested in 28 companies across regions including North America, Europe, and Asia Pacific (excluding India and China). 27V typically invests at the pre-seed and seed stages, with initial checks ranging from $50,000 to $250,000, and reserves funds for follow-on investments. The firm is more than just a fund; it promotes a "Founder Fellowship" that emphasizes community and connections among founders and their teams, facilitating shared learning and support. Notable investments in their portfolio include companies like Fluent, which aims to revolutionize language learning, and Preteckt, which uses machine learning to predict maintenance issues in vehicles. 27V's unique approach includes a scout network that helps identify promising startups from underrepresented communities, fostering diversity and inclusion in the venture capital ecosystem.
2xN is a London-based, quantum-focused venture capital fund co-founded by Lars Fjeldsoe-Nielsen and Niels Nielsen. The firm specializes in early-stage investments, primarily targeting startups in quantum computing and other sectors with transformative potential like mobility, edtech, and marketplaces. Notable investments include quantum heavyweights Quantinuum and Kvantify, as well as StudySmarter, demonstrating its focus on impactful technologies. With a $120 million fund, 2xN typically invests $3 to $5 million in pre-seed to Series A rounds, actively backing companies across Europe and the U.S. The fund's strategy is highly collaborative, often co-investing with prominent VCs like Sequoia and A16Z, favoring founders with a vision for societal impact. Rather than dominating deals, 2xN aims to create network effects and long-term partnerships, making them a hands-on, founder-first investor. The team’s dual expertise—Nielsen’s pioneering work in quantum computing and Fjeldsoe-Nielsen’s background in Silicon Valley—enables them to offer deep, technical guidance while scaling businesses rapidly. Startups are encouraged to approach the fund with disruptive ideas in core sectors like quantum, as 2xN builds its deal flow through a strong network of repeat entrepreneurs and global investors.
Three0 is a boutique venture fund and incubator focused on fostering disruptive, high-growth startups, particularly in the Web 3.0 space. Based in Miami, the fund plays a key role in nurturing the city’s entrepreneurial ecosystem. Three0 is selective, only partnering with founders whose vision aligns with their goal of reshaping industries through innovation. The team provides hands-on support, helping companies with product development, market strategy, and scaling. Their portfolio reflects a focus on emerging technologies, especially blockchain and crypto-related ventures. Notable investments include Protecc Labs, a cybersecurity startup, and initiatives in the metaverse and decentralized finance spaces. The fund looks for founders with bold, scalable ideas and offers support beyond capital, including feasibility assessments and private equity fundraising strategies. Three0's geographic focus is primarily North America, though they also explore opportunities in Europe. Their strategy revolves around making early-stage investments in startups with strong technical foundations and the potential for rapid market adoption. The fund often leads seed rounds, deploying checks between $500K and $2M, and takes an active role in shaping the companies they back. Led by Marouf Tirad, the fund has a dynamic team of technologists and creative professionals who ensure that their portfolio companies receive both financial and strategic guidance. Startups looking to collaborate with Three0 should prepare a clear vision for scalability and be ready for a hands-on partnership approach.
305 Ventures, based in Miami, is a venture capital firm that focuses on early-stage investments, primarily targeting pre-seed and seed-stage companies across diverse sectors. Founded by Zaid Rahman, Joey Levy, and Michael Melikian in 2021, the firm is run by active founders who invest in other entrepreneurs, helping them navigate growth challenges with hands-on support and strategic guidance. 305 Ventures has a broad investment scope, ranging from fintech, sports media, entertainment, and web3 to consumer products. Their portfolio includes notable companies such as Underdog Fantasy, Rain (a fintech platform), Voldex (a Roblox and Minecraft game developer), Betr (a micro-betting app), and Los Dos Tequila. The firm has also invested in companies that leverage web3 and NFTs, such as Passes and Dropverse. The firm is committed to accelerating Miami's emergence as a tech hub, attracting founders from cities like LA, New York, and Silicon Valley, and helping them integrate into the local ecosystem. 305 Ventures often partners with Florida Funders and other co-investors to support startups in scaling their operations while building a robust community in Miami. With plans to invest in 40 companies, the firm is set on nurturing the next generation of billion-dollar businesses.
32 Advisors, founded by Robert Wolf in 2012, is a boutique consulting firm with a focus on cross-border business advisory. The firm offers strategic guidance in areas like international market access, trade, project finance, and strategic intelligence. Their unique advisory services target sectors such as infrastructure, exports, and foreign direct investment (FDI), often working with public and private institutions to facilitate cross-border growth. Their investment arm, 32 Ventures, has backed innovative companies across various industries. Notable investments include Measure, a drone intelligence company (acquired by AgEagle), and Illumio, a leader in micro-segmentation cybersecurity. They have also invested in fintech, like Keyno, which revolutionizes credit card security with dynamic CVV codes. With a focus on both U.S. and international markets, 32 Advisors works extensively in regions like Sub-Saharan Africa, facilitating infrastructure and energy projects. Wolf leads a seasoned team, including former government and Wall Street professionals, such as Austan Goolsbee and Kevin Varney, offering clients a wealth of global experience. The firm’s strategic intelligence and public policy expertise further distinguish it from traditional advisory firms. 32 Advisors works closely with high-growth businesses, NGOs, and governments, ensuring tailored solutions that address both strategic and operational challenges.
360 Capital Partners is a prominent early-stage venture capital firm based in Europe, with offices in Paris and Milan. The firm invests from pre-seed to Series B stages, focusing on deep tech, climate tech, and digital-first solutions. They support startups that have the potential to disrupt traditional business models and drive technological innovation. The firm has a diverse portfolio of over 150 startups, with notable investments including Prophesee, Exotec, and Energy Dome. Their portfolio reflects a commitment to backing technologies that emerge from cutting-edge research and have the power to reshape entire industries. 360 Capital Partners also collaborates closely with institutions like Politecnico di Milano to accelerate technological advancements. Geographically, 360 Capital Partners concentrates on Europe, leveraging a robust network and extensive expertise to help entrepreneurs scale their businesses to their full potential. The firm's strategy emphasizes sustainable technological progress, aligning investments with the global push for climate change solutions and the digital transformation of various sectors. The team at 360 Capital Partners comprises experienced professionals such as Alessandro Zaccaria and Alexandre Mordacq, who bring valuable insights and strategic support to their portfolio companies. The firm's long-standing presence in the European VC ecosystem and its forward-thinking investment philosophy make it a key player in driving innovation and growth in the region.
360 Capital Group, listed on the ASX, is a specialized investment and fund management firm with a strategic focus on real estate and credit investments across Australia, New Zealand, and the Asia Pacific region. They excel in core real estate assets, opportunistic investments, and credit facilities, including senior and junior debt, with a particular emphasis on value-added opportunities. In partnership with PMG Funds in New Zealand, 360 Capital actively manages over NZD $675 million in assets, tapping into diverse investment sources to drive robust returns across high-quality properties and debt instruments. Under the leadership of founder and Executive Chairman Tony Pitt, who has more than 25 years of expertise, the team combines substantial experience in property fund management, mergers, and capital markets. Known for strategic agility, the firm leverages a team of sector-specific experts who ensure well-governed, steady growth while adapting swiftly to changing market dynamics. Their investment strategy targets stable, income-generating assets alongside innovative acquisitions in high-growth areas like hospitality, where they focus on hotel property across the Asia Pacific. Investors are attracted to their 11% annual return target from structured investments and direct credit, managed through REITs like the 360 Capital REIT and Mortgage REIT. Startups and partners are encouraged to engage early with their dedicated team, known for meticulous execution in competitive sectors. With a legacy of corporate strength and rigorous governance, 360 Capital consistently pursues growth while maintaining investor confidence. 360 Capital typically invests during seed and Series A rounds, supporting startups with a vision to drive technological disruption. The fund is known to lead investments but also collaborates actively with other investors to scale up its portfolio companies. With an average check size of about €12 million, it seeks ventures that align with its long-term growth strategies. The leadership includes figures like Alexandre Mordacq and Cesare Maifredi, who bring extensive experience across various sectors, driving the firm's strategic vision. For startups looking to engage, it is advisable to have a clear, innovation-driven pitch that emphasizes scalability and technological impact, as 360 Capital prioritizes companies that show promise for significant market disruption.
360 Venture Collective is a woman-founded and led venture capital firm based in Miami, focusing on pre-seed and seed-stage investments. The firm is dedicated to supporting historically underestimated founders, particularly women and LGBTQ+ entrepreneurs, across sectors like fintech, healthtech, proptech, and the future of work. Their inclusive investment strategy aims to foster innovation while driving social impact. Founded in 2021, the firm typically invests between $50,000 and $500,000 per venture. They also provide operational and strategic support through their Arc Accelerator, helping startups scale effectively. Key team members include Managing Partner Kelly O'Connell and General Partners Ann Metzger and Shelley Iocona, all of whom bring extensive experience in entrepreneurship and corporate leadership. Recent investments include startups like HUSSLUP and Upside Health, demonstrating 360 Venture Collective's focus on high-potential, tech-enabled businesses.
37 Angels is an angel investment network founded in 2012, headquartered in New York, NY. The firm is dedicated to closing the gender gap in startup investing by training more women to become angel investors and by investing in high-potential, diverse startups. Each year, 37 Angels evaluates around 2,500 startups and invests in approximately 10, focusing on both male and female-led companies. Their portfolio includes a variety of innovative startups across different sectors. Notable investments include ChalkTalk, an e-learning platform, Partake Foods, a food products company, and EarlyBird, a financial software firm. They also have significant investments in companies like Pulp Pantry, which focuses on sustainable food products, and Sensate, which provides health and wellness solutions. 37 Angels has had multiple successful exits, such as Owlet Baby Care, which went public, and Kinsa Health, which was acquired by a larger firm. Their investment strategy involves supporting startups from early stages through to growth, offering both capital and strategic guidance to help them scale.
3B Ventures is an impact-driven venture capital firm founded in 2017 with headquarters in Copenhagen, Denmark. The fund primarily focuses on solving global challenges through investments in key sectors like agribusiness, clean-tech, energy, and healthcare. It has a global reach, with a particular focus on markets in Malaysia, Europe, and the United States. The firm targets early-stage startups and seed-stage companies that are developing innovative solutions with potential for significant impact. 3B Ventures has been involved in notable investments like AnaCardio, a biopharma company focused on medical advancements, where they participated in a substantial $18 million funding round. The fund’s average deal size is around $18 million, indicating that it takes a substantial approach to backing its portfolio companies. Founded by James Digby and Jan-Cayo Fiebig, 3B Ventures is committed to not only providing capital but also delivering strategic support to help companies scale and solve large-scale global problems. The firm tends to look for entrepreneurs passionate about creating change, with business models that align with their vision for a sustainable and impactful future. They prefer to work with founders who have a clear path to growth and profitability, and they actively engage in nurturing these businesses through their extensive network and resources. Entrepreneurs looking to approach 3B Ventures are encouraged to present well-developed solutions with demonstrable traction in key markets.
3CC | Third Culture Capital is a Boston-based venture capital firm that focuses on early-stage investments at the intersection of healthcare, human capital, and financial capital. Founded with a mission to drive diversity, innovation, and equity in healthcare, 3CC invests in startups that bring together cross-cultural and cross-disciplinary approaches to healthcare innovation. The firm’s unique name, "Third Culture," reflects its commitment to supporting entrepreneurs with diverse backgrounds who are poised to disrupt traditional healthcare models. 3CC’s investment strategy targets innovations that can improve patient outcomes, reduce costs, and enhance the overall experience of care for both patients and providers. The firm typically makes investments ranging from $250,000 to $1 million, and prefers to lead funding rounds, providing not just capital but also strategic support through its extensive network of healthcare professionals. 3CC’s portfolio includes companies that are making significant strides in various healthcare sectors, such as Ciba Health, Voiceitt, and Pragma Bio, each focused on leveraging technology to solve critical healthcare challenges. The firm is deeply committed to fostering a more inclusive and innovative healthcare industry by lowering barriers to entry for underrepresented entrepreneurs and promoting collaborative decision-making.
3E Bioventures Capital is a prominent venture capital firm specializing in the life sciences sector, focusing on innovative therapeutic drugs and disruptive med-tech. Founded with a mission encapsulated in their name—Expertise, Efficiency, Execution—3E Bioventures actively invests in global health innovators and TechBio, aiming to disrupt conventional paradigms by integrating biology with technology. Notable investments include Aravive, which develops biologic drugs targeting tumor metastasis, and C4 Therapeutics, which pioneers small-molecule drugs that degrade disease-causing proteins. Their portfolio also boasts companies like Cytek, which offers a transformative flow cytometry platform, and Twist Bioscience, known for its advanced DNA synthesis technology. Geographically, 3E Bioventures operates with a global perspective, maintaining a strong presence in the US and China. They often participate in early-stage and growth-stage investments, providing significant support in both capital and strategic guidance. The firm’s team includes experienced professionals such as Li Jing, Frank Yan, and Linda Liu, who leverage their deep industry knowledge to support portfolio companies effectively. They emphasize a science-driven, entrepreneur-friendly approach, working closely with research institutions and companies to address unmet medical needs. For startups seeking investment, 3E Bioventures looks for breakthrough innovations in biotech and med-tech, focusing on areas with strong medical needs and the potential for significant impact. They prefer to engage with companies that align with their strategic goals and demonstrate a clear pathway to success.
3LB Seed Capital is a venture capital firm based in Turin, Italy, focusing on early-stage investments in innovative startups, particularly those in Italy and the EU. The firm typically invests between €30k and €60k in startups, often becoming the first investor outside the founders' circle. For larger investments, up to €500k, they partner with other investors and syndicates. Their portfolio includes diverse sectors, with a notable balance between digital and hardware-focused companies. Key investments include Quantum Bridge in cybersecurity, Axelera AI in hardware and AI, NewCleo in climate tech, D-Orbit in space technology, and Anthropic in AI software. They have seen successful exits, including Electra Vehicles and Metis Precision Medicine. 3LB Seed Capital emphasizes a hands-on approach, providing strategic support and leveraging their network to help startups grow and raise additional capital. The firm aims to foster strong relationships with entrepreneurs, acting as business partners to support the development and success of their ventures.
3Lines Venture Capital is a Denver-based venture capital firm that was founded in 2016. The firm primarily focuses on early-stage investments in companies leveraging AI and disruptive software technologies, particularly in sectors related to the Future of Work, enterprise solutions, and industry innovations. The firm's investment strategy involves funding startups that are poised to drive significant technological advancements and market transformations. 3Lines has built a robust portfolio that includes notable companies such as Swimlane, a leader in cybersecurity automation, and Arzooo, an Indian retail technology company. Other investments include Aarna Networks in cloud computing and telecommunications, and Tastry, an AI-driven sensory sciences company based in California. 3Lines Venture Capital is known for its strategic approach, often co-investing with other prominent venture capital firms and leveraging a unique investor engagement model that includes managed funds, co-investments, and venture debt. The firm has successfully closed multiple funding rounds, with their second fund closing at $26 million, surpassing the initial target of $20 million. They plan to launch a $100 million Orbit Fund to further expand their investment capabilities. The leadership team at 3Lines includes seasoned professionals with extensive experience in venture capital, technology, and entrepreneurship. Notable members include Hemant Elhence, Operating Partner, and Anil Gupta, Managing Partner for India, both bringing decades of industry expertise to the firm.
3M Ventures, the corporate venture capital arm of 3M, focuses on investing in early-stage companies that align with 3M's strategic priorities. These priorities include automotive electrification, safety, home improvement, consumer electronics, climate tech, sustainable packaging, industrial automation, and semiconductor and data center technologies. Their investment strategy targets companies with strong intellectual property, demonstrated commercial traction, and robust management teams. Notable investments by 3M Ventures include GrayMatter Robotics, Moxe Health, and Metalenz, which span across artificial intelligence, healthcare, and 3D technology, respectively. 3M Ventures seeks to not only provide financial investment but also leverage 3M's extensive technological platforms, manufacturing capabilities, and global networks to help scale their partner companies. 3M is also heavily committed to sustainability. The company has pledged $1 billion to achieve carbon neutrality, reduce water use, and improve water quality by 2030. This initiative includes implementing state-of-the-art water purification technology and developing innovative solutions for renewable energy and emissions reduction.
3one4 Capital is a Bangalore-based early-stage venture capital firm with over $750 million in assets under management. Known for its disciplined investment strategy, the firm has successfully raised $200 million for its latest fund, focusing on technology-driven startups in sectors like SaaS, fintech, consumer internet, and enterprise digitization. Its portfolio includes notable companies such as Licious, Darwinbox, Open, Jupiter, and Koo. The firm was co-founded by Pranav and Siddarth Pai, who lead the charge in identifying and nurturing high-potential startups. They focus on early-stage investments, with typical checks ranging from $500K to $5 million, and offer LPs opportunities for direct co-investment. This deep engagement strategy allows 3one4 to maintain strong portfolio relationships from seed through growth stages. 3one4 also explores newer areas such as climate tech and digital health, aiming to back transformative companies that cater to India’s growing digital economy. With a proven track record of creating unicorns, the firm is one of the top-performing VC funds in India, boasting industry-leading returns. The team includes partners like Anurag Ramdasan and Nruthya Madappa, who bring their expertise to further scale portfolio companies.
3SE Holdings, founded in 2022 and based in Chatham, New Jersey, was a venture capital firm focusing on investments in financial services, IT, and cryptocurrency sectors. The firm made approximately eight investments in various startups, including Nifty League, Dahlia Labs, and Automatica, before becoming inactive. 3SE Holdings specialized in early-stage investments, particularly within software and IT consulting, seeking to back innovative companies with strong growth potential. Over its short existence, the firm exited six of its portfolio companies through secondary transactions. Despite its brief tenure, 3SE Holdings positioned itself to support startups through seed and venture rounds, helping them navigate their early growth stages. With a focus on cutting-edge industries like cryptocurrency and fintech, the firm sought to invest in companies generating revenue, providing them with both financial backing and strategic guidance. However, the firm is no longer operational, making its mark in a few notable exits before closing.
3VC is a European venture capital fund that focuses on investing in tech startups with global ambitions, primarily at the Series A stage. They are known for their hands-on support and strong partnerships with founders, offering not only capital but also strategic guidance and connections to help startups grow and succeed. Notable investments by 3VC include simpleclub, an education technology platform; Creatopy, a graphic design platform; Storyblok, a headless CMS platform; and Assaia, which provides AI solutions for airport ground operations. Their approach emphasizes understanding the specific markets their portfolio companies operate in, and they are known for their proactive support throughout the investment process. 3VC was co-founded by Peter Lasinger and Roman Scharf, who bring extensive entrepreneurial and investment experience. The firm is dedicated to investing responsibly and supporting the growth of their portfolio companies with a strong focus on quality partnerships and sustainable development
3x5 Partners is a Portland, Oregon-based venture capital firm that focuses on investments in companies developing solutions for global health and climate challenges. Founded in 2011 by Tony Arnerich and Nicholas Walrod, the firm has raised over $400 million across multiple funds, including their most recent $100 million Fund III. 3x5 Partners primarily invests in late-stage (Series A/B) ventures within sectors such as biotechnology, medical devices, diagnostics, and clean technology. The firm is known for its commitment to long-term partnerships, often leading early investment rounds and providing significant follow-on funding. Notable investments include companies like Fervo Energy, Arch Oncology, and Smart Wires, all of which align with their mission to create meaningful social and environmental impact. 3x5 Partners differentiates itself by focusing on capital-intensive, high-impact ventures that are often overlooked by traditional venture capital firms. They take an active role in the companies they invest in, serving as board members and strategic partners to guide these ventures through critical growth stages. The firm's leadership team, which includes seasoned investors like Joe Biller and David Yeh, is deeply experienced in both impact investing and venture capital, ensuring that they not only generate strong returns for their investors but also contribute to solving some of the world's most pressing problems.
415 Capital is a Munich-based venture capital firm that specializes in investing in breakthrough medical technologies, particularly those addressing critical unmet needs in cardiovascular and neurovascular diseases. With a focus on improving patient outcomes and reducing healthcare costs, 415 Capital invests in startups across Europe, Israel, and North America, typically writing checks between €5 million and €15 million per company. The firm’s portfolio boasts several cutting-edge companies like Supira Medical, which is developing a percutaneous ventricular assist device for high-risk heart patients, and Distalmotion, known for its innovative surgical robotics platform. 415 Capital avoids biotech, healthcare services, and wellness products, honing in exclusively on medtech innovations. Their strategy emphasizes deep involvement from the R&D stage through commercialization, leveraging close relationships with healthcare providers and access to a €2 billion commercial channel in Europe. The firm’s team combines expertise in investment, medical device commercialization, and clinical practice, ensuring they remain at the forefront of medical innovation. Historically, 415 Capital has been part of significant advancements such as the development of transcatheter heart valves and renal denervation technologies. Their approach to venture capital is deeply rooted in the belief that pioneering medical technologies can simultaneously improve healthcare and generate substantial returns.
42CAP, established in 2016 and based in Munich, Germany, is a venture capital firm that focuses on seed-stage investments in B2B technology startups across Europe. The firm is notable for its emphasis on data-driven and SaaS companies, with a strong interest in applications of artificial intelligence and machine learning. Their portfolio includes notable startups like Adverity, a marketing analytics platform, and OnTruck, a real-time marketplace for truck deliveries. 42CAP typically invests between €0.5 million and €1.5 million per company and aims to back ventures that can scale globally from a European base. 42CAP's strategic approach involves partnering with visionary founders to drive technological innovations in B2B sectors. They seek companies that enable organizational agility and efficiency, particularly in fields such as big data and IoT. Their latest fund, totaling €50 million, is set to support approximately 20 startups, expanding on the success of their initial investments. The team behind 42CAP includes experienced entrepreneurs and investors like Alex Meyer and Thomas Wilke, who previously built successful companies such as eCircle and Relayr. This diverse and experienced team is integral to their hands-on approach in supporting portfolio companies from early stages to market leadership.
43.io is a unique pre-product venture capital fund dedicated to helping founders navigate the early stages of their startup journey, even before product-market fit is achieved. The fund is renowned for leading the earliest rounds and writing first checks, often when a company has no product, traction, or significant social proof. With a high-conviction approach, 43.io typically seeks a 5% ownership stake and limits each investor to only five investments annually. This allows the team to work closely with founders, providing not just capital but strategic guidance and operational support throughout their growth. Founded by experienced investors and operators, the team includes Dustin, who previously co-founded Spearhead and has invested in companies like Patreon and PillPack; Anabel, an expert in people operations who scaled Opendoor from 30 to 600 employees; and Soso, who bootstrapped Growth Pilots and oversaw massive ad campaigns for companies like Instacart and Zapier. Together, they bring deep expertise in scaling, growth marketing, and people management. Geographically agnostic and sector-neutral, 43.io targets startups across various industries, making it ideal for mission-driven founders seeking a high-touch partner. The fund’s strategy emphasizes active participation, leveraging networks and experience to help startups overcome early challenges. Founders are encouraged to approach 43.io at the very beginning of their journey, as the team excels in providing support before product development. This combination of early investment and operational assistance makes 43.io a go-to partner for ambitious startups looking for a dedicated, hands-on investor.
468 Capital is a venture capital firm headquartered in Berlin and San Francisco, specializing in early-stage investments across various high-tech sectors. Founded in 2020 by Ludwig Ensthaler and Florian Leibert, the firm focuses on technologies that redefine markets, particularly in automation, electrification, software, and consumer/prosumer sectors. Notable investments in their portfolio include companies like Rapid Robotics, Worldcoin, and Superchat, showcasing their interest in innovative and transformative technologies. 468 Capital has made a total of 164 investments, with recent notable exits including natif.ai and Talentspace. The firm's investment strategy is thematic and high-conviction, emphasizing versatility, global reach, and big thinking. This approach is backed by a strong network of founders, operators, and investors, helping portfolio companies grow and achieve significant milestones, including public listings. Their team combines technological expertise with deep market knowledge, enabling them to make agile investment decisions and provide substantial support to their portfolio companies. With offices in Berlin, Madrid, and San Francisco, 468 Capital is well-positioned to support startups in raising global capital, growing teams, and launching products internationally.
4BIO Capital is a London-based venture capital firm specializing in advanced therapies, particularly in areas like gene therapy, cell therapy, RNA-based treatments, and the microbiome. The firm is focused on addressing high unmet medical and social needs through early-stage investments in innovative life sciences companies. Founded by a team of experienced academics, physician-scientists, and industry executives, 4BIO Capital has built a strong reputation for its deep expertise in the rapidly evolving field of advanced therapies. The firm’s strategy involves not only backing early-stage startups but also creating new companies by leveraging cutting-edge research from academic institutions across Europe and the U.K. 4BIO Capital recently raised $50 million for its second advanced therapy VC fund, with plans to increase this to $150 million. This fund is dedicated to expanding the use of advanced therapies beyond rare diseases to treat more prevalent conditions like diabetes and rheumatoid arthritis. The firm has a global investment focus, with no geographical restrictions, though it emphasizes the untapped potential within U.K. institutions. The team at 4BIO includes managing partners Dmitry Kuzmin and Andrew Kozlov, who bring a wealth of knowledge and experience in life sciences and venture investing, helping to drive the firm’s mission of bringing transformative therapies to market.